share_log

12 Health Care Stocks Moving In Friday's After-Market Session

Benzinga ·  Mar 30 04:30

Gainers

  • Qilian Intl Hldg Gr (NASDAQ:QLI) shares rose 63.8% to $1.04 during Friday's after-market session. The market value of their outstanding shares is at $37.1 million.
  • Sunshine Biopharma (NASDAQ:SBFM) stock moved upwards by 39.5% to $0.08. The company's market cap stands at $8.3 million.
  • Galera Therapeutics (NASDAQ:GRTX) shares increased by 28.57% to $0.18. The company's market cap stands at $9.7 million. As per the news, the Q4 earnings report came out yesterday.
  • Medpace Hldgs (NASDAQ:MEDP) shares rose 18.76% to $480.0. The market value of their outstanding shares is at $14.7 billion.
  • Xilio Therapeutics (NASDAQ:XLO) shares rose 17.59% to $1.29. The company's market cap stands at $35.5 million.
  • VYNE Therapeutics (NASDAQ:VYNE) shares rose 13.02% to $3.47. The company's market cap stands at $48.9 million.

Losers

  • Vivos Therapeutics (NASDAQ:VVOS) shares fell 22.4% to $3.75 during Friday's after-market session. The market value of their outstanding shares is at $4.9 million. As per the news, the Q4 earnings report came out yesterday.
  • ENDRA Life Sciences (NASDAQ:NDRA) shares decreased by 19.54% to $0.47. The company's market cap stands at $5.1 million. As per the news, the Q4 earnings report came out yesterday.
  • Applied Therapeutics (NASDAQ:APLT) shares fell 15.15% to $5.77. The company's market cap stands at $610.9 million.
  • Biophytis (NASDAQ:BPTS) shares decreased by 11.43% to $0.31. The company's market cap stands at $3.5 million.
  • Pulse Biosciences (NASDAQ:PLSE) shares fell 10.68% to $7.78. The market value of their outstanding shares is at $428.5 million. As per the press release, Q4 earnings came out yesterday.
  • Biote (NASDAQ:BTMD) stock decreased by 10.18% to $5.21. The market value of their outstanding shares is at $186.0 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment